Shire Orphan Therapies LLC et al v. Fresenius Kabi USA, LLC > Summary
Court Case Number 1:15-cv-01102
Filing Date Nov 30, 2015
Court Delaware District Court
Status Unknown
Appeal2018-2124
Defendant
Plaintiff Attorneys
7Takeda Pharmaceutical Company Limited
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Takeda Pharmaceutical Company Limited
Attorney Name: Laura A. Chubb
Haug Partners
Takeda Pharmaceutical Company Limited
Attorney Name: Laura A. Sarkis
Haug Partners
Takeda Pharmaceutical Company Limited
Attorney Name: Edgar H. Haug
Haug Partners
Takeda Pharmaceutical Company Limited
Attorney Name: Sandra Kuzmich
Haug Partners
Takeda Pharmaceutical Company Limited
Attorney Name: Ying-Zi Yang
Haug Partners
Defendant Attorneys
5Fresenius Kabi USA
Attorney Name: William G. James II
Goodwin Procter LLP
Fresenius Kabi USA
Attorney Name: Karen E. Keller
Shaw Keller LLP
Fresenius Kabi USA
Attorney Name: John W. Shaw
Shaw Keller LLP
Fresenius Kabi USA
Attorney Name: Coy Stull
Goodwin Procter LLP
Fresenius Kabi USA
Attorney Name: Daryl L. Wiesen
Goodwin Procter LLP
Counter Defendant
2Counter Claimant
Fresenius Kabi USA
Attorney Name: Karen E. Keller
Shaw Keller LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 05648333 | Peptides having bradykinin antagonist action | Jul 15, 1997 |
